Update Please, page-2

Yes it's all gone a bit quiet.

This is taken from the presentation showing what announcements are due:


In terms of market cap / share price things should move a little once the first patient is treated. Until that time the price will stay as it is imo. Timeline? not sure when that will be, hopefully soon.

The NASDAQ-listed company Chemocentryx is probably the closest comparison to SBN however they are ahead in terms of trials.